Literature DB >> 23509124

Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii.

Sonaimuthu Parthasarathy1, Mun Yik Fong, Kalyanasundaram Ramaswamy, Yee Ling Lau.   

Abstract

Toxoplasmosis in humans and other animals is caused by the protozoan parasite Toxoplasma gondii. During the process of host cell invasion and parasitophorous vacuole formation by the tachyzoites, the parasite secretes Rhoptry protein 8 (ROP8), an apical secretory organelle. Thus, ROP8 is an important protein for the pathogenesis of T. gondii. The ROP8 DNA was constructed into a pVAX-1 vaccine vector and used for immunizing BALB/c mice. Immunized mice developed immune response characterized by significant antibody responses, antigen-specific proliferation of spleen cells, and production of high levels of IFN-γ (816 ± 26.3 pg/mL). Challenge experiments showed significant levels of increase in the survival period (29 days compared with 9 days in control) in ROP8 DNA vaccinated mice after a lethal challenge with T. gondii. Results presented in this study suggest that ROP8 DNA is a promising and potential vaccine candidate against toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23509124      PMCID: PMC3752752          DOI: 10.4269/ajtmh.12-0727

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

1.  Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents.

Authors:  C W Angus; D Klivington-Evans; J P Dubey; J A Kovacs
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

2.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

Authors:  R T Gazzinelli; F T Hakim; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

Review 3.  Vaccines against Toxoplasma gondii: challenges and opportunities.

Authors:  Erik Jongert; Craig W Roberts; Nicola Gargano; Elisabeth Förster-Waldl; Elisabeth Förster-Wald; Eskild Petersen
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

4.  Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii.

Authors:  Wei Qiu; Amy Wernimont; Keliang Tang; Sonya Taylor; Vladimir Lunin; Matthieu Schapira; Sarah Fentress; Raymond Hui; L David Sibley
Journal:  EMBO J       Date:  2009-02-05       Impact factor: 11.598

Review 5.  A commercial vaccine for ovine toxoplasmosis.

Authors:  D Buxton; E A Innes
Journal:  Parasitology       Date:  1995       Impact factor: 3.234

6.  Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice.

Authors:  Zi-Guo Yuan; Xiu-Xiang Zhang; Xian-Hui He; Eskild Petersen; Dong-Hui Zhou; Yong He; Rui-Qing Lin; Xiu-Zhen Li; Xu-Li Chen; Xiao-Ru Shi; Xiu-Ling Zhong; Bing Zhang; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

7.  Toxoplasmosis: the first commercial vaccine.

Authors:  D Buxton
Journal:  Parasitol Today       Date:  1993-09

Review 8.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

Review 9.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

Review 10.  Regulation of CD8+ T cell responses to infection with parasitic protozoa.

Authors:  Kimberly A Jordan; Christopher A Hunter
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

View more
  12 in total

1.  Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice.

Authors:  Xiao Teng Ching; Mun Yik Fong; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice.

Authors:  Qing Tao; Rui Fang; Weichao Zhang; Yifan Wang; Jianxi Cheng; Yalin Li; Kun Fang; Muhammad Kasib Khan; Min Hu; Yanqin Zhou; Junlong Zhao
Journal:  Parasitol Res       Date:  2013-06-10       Impact factor: 2.289

Review 3.  REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII.

Authors:  Rosalie C Warner; Ryan C Chapman; Brianna N Davis; Paul H Davis
Journal:  J Parasitol       Date:  2021-11-01       Impact factor: 1.276

4.  Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.

Authors:  Nahiara Esteves Zorgi; Andrés Jimenez Galisteo; Maria Notomi Sato; Nanci do Nascimento; Heitor Franco de Andrade
Journal:  Med Microbiol Immunol       Date:  2016-01-05       Impact factor: 3.402

Review 5.  Mechanisms of cellular invasion by intracellular parasites.

Authors:  Dawn M Walker; Steve Oghumu; Gaurav Gupta; Bradford S McGwire; Mark E Drew; Abhay R Satoskar
Journal:  Cell Mol Life Sci       Date:  2013-11-13       Impact factor: 9.261

Review 6.  Recent advances in Toxoplasma gondii immunotherapeutics.

Authors:  Sherene Swee-Yin Lim; Rofina Yasmin Othman
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

7.  Induction of Protective Immunity against Toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1.

Authors:  Parthasarathy Sonaimuthu; Xiao T Ching; Mun Y Fong; Ramaswamy Kalyanasundaram; Yee L Lau
Journal:  Front Microbiol       Date:  2016-05-27       Impact factor: 5.640

8.  Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.

Authors:  Pengxia Song; Shenyi He; Aihua Zhou; Gang Lv; Jingjing Guo; Jian Zhou; Yali Han; Huaiyu Zhou; Zhen Hao; Hua Cong
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

9.  Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.

Authors:  Shuai Wang; YuJian Wang; XiaoNi Sun; ZhenChao Zhang; TingQi Liu; Javaid Ali Gadahi; Ibrahim Adam Hassan; LiXin Xu; RuoFeng Yan; XiaoKai Song; XiangRui Li
Journal:  BMC Infect Dis       Date:  2015-10-24       Impact factor: 3.090

10.  DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice.

Authors:  Hai-Long Wang; Yu-Jing Wang; Yan-Jiang Pei; Ji-Zhong Bai; Li-Tian Yin; Rui Guo; Guo-Rong Yin
Journal:  Parasite       Date:  2016-02-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.